Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency

Summary

This is a Multi-national Trial. The Goal of the Trial is to Offer Subjects Who Complete 12 Months in the LUM-201-10 Phase 3 Trial up to an Additional 36 Months of Treatment of LUM-201 While Evaluating Safety and Tolerability of LUM-201.

Timeline

Start

2027-02

Primary completion

2030-02

Completion

2030-02

Drugs

Indications